Ikena Oncology Inc (IKNA): This is a very inactive board, but IKNA...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Ikena Oncology Inc (IKNA)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	2
Posts	188
Boards Moderated	0
Alias Born	01/09/2019

Re: None

Sunday, 01/29/2023 12:40:26 PM

Sunday, January 29, 2023 12:40:26 PM

This is a very inactive board, but IKNA is worth keeping an eye on. I currently do not own any but am interested enough to follow it. Right now my biggest interest is in IKNA's new molecule IK-595- the RAF:MEK clamp. They intend to file and IND application in 2H2023. I see very big future potential for IK-595 and want to see how IKNA develops it's early clinical plan.

I am not too familiar with there lead drug so I am neutral regarding it.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent IKNA News

Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum • GlobeNewswire Inc. • 04/10/2024 12:00:00 PM
Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/12/2024 12:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:05:21 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:01:16 PM
Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/27/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:29:08 PM
Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer • GlobeNewswire Inc. • 02/21/2024 09:15:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 10:15:05 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 10:07:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:26:52 PM
Ikena Oncology Outlines Key Priorities and Provides Corporate Updates • GlobeNewswire Inc. • 01/18/2024 09:05:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 12:30:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 12:09:22 PM
Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/09/2023 12:00:00 PM
Ikena Oncology to Present at Multiple November 2023 Investor Conferences • GlobeNewswire Inc. • 11/07/2023 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 09:10:53 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/25/2023 08:05:20 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/15/2023 08:05:57 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/12/2023 08:11:09 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/11/2023 04:15:23 AM
Ikena Oncology to Participate in September 2023 Investor Conferences • GlobeNewswire Inc. • 09/05/2023 12:00:00 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/18/2023 08:02:27 PM
Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate Update • GlobeNewswire Inc. • 08/10/2023 12:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 11:00:57 AM

More IKNA News

InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow